92 related articles for article (PubMed ID: 7474630)
1. [Expression of GP160 mRNA in renal cell carcinoma: an attempt to predict the sensitivity of IFN-alpha therapy].
Kimura F; Shimizu S; Tsuji A; Nakajima F; Hayakawa M; Nakamura H
Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1424-8. PubMed ID: 7474630
[TBL] [Abstract][Full Text] [Related]
2. Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas.
Geng Y; Biffi A; Engelstein D; Ronch E; Faustini M; Lai HK; Albino AP; Di Fronzo G; Nanus DM
Anticancer Res; 1998; 18(1A):1-7. PubMed ID: 9568047
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein.
Nanus DM; Pfeffer LM; Bander NH; Bahri S; Albino AP
Cancer Res; 1990 Jul; 50(14):4190-4. PubMed ID: 2364374
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A.
Nanus DM; Engelstein D; Gastl GA; Gluck L; Vidal MJ; Morrison M; Finstad CL; Bander NH; Albino AP
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7069-73. PubMed ID: 8346219
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
Kehlen A; Göhring B; Langner J; Riemann D
Clin Exp Immunol; 1998 Feb; 111(2):435-41. PubMed ID: 9486416
[TBL] [Abstract][Full Text] [Related]
6. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
[TBL] [Abstract][Full Text] [Related]
7. A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters.
Schwaab T; Heaney JA; Schned AR; Harris RD; Cole BF; Noelle RJ; Phillips DM; Stempkowski L; Ernstoff MS
J Urol; 2000 Apr; 163(4):1322-7. PubMed ID: 10737537
[TBL] [Abstract][Full Text] [Related]
8. Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions.
Pfeffer LM; Wang C; Constantinescu SN; Croze E; Blatt LM; Albino AP; Nanus DM
J Urol; 1996 Nov; 156(5):1867-71. PubMed ID: 8863634
[TBL] [Abstract][Full Text] [Related]
9. Aminopeptidase A expression and enzymatic activity in primary human renal cancers.
Nanus DM; Bogenrieder T; Papandreou CN; Finstad CL; Lee A; Vlamis V; Motzer RJ; Bander NH; Albino AP; Reuter VE
Int J Oncol; 1998 Aug; 13(2):261-7. PubMed ID: 9664120
[TBL] [Abstract][Full Text] [Related]
10. Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.
Sonouchi K; Hamilton TA; Tannenbaum CS; Tubbs RR; Bukowski R; Finke JH
Am J Pathol; 1994 Apr; 144(4):747-55. PubMed ID: 8160774
[TBL] [Abstract][Full Text] [Related]
11. Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma.
Kriegmair M; Oberneder R; Hofstetter A
Urology; 1995 May; 45(5):758-62. PubMed ID: 7747370
[TBL] [Abstract][Full Text] [Related]
12. Rat kidney glutamyl aminopeptidase (aminopeptidase A): molecular identity and cellular localization.
Song L; Ye M; Troyanovskaya M; Wilk E; Wilk S; Healy DP
Am J Physiol; 1994 Oct; 267(4 Pt 2):F546-57. PubMed ID: 7943354
[TBL] [Abstract][Full Text] [Related]
13. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
[TBL] [Abstract][Full Text] [Related]
14. Effects of retinoic acid and interferon-gamma on expression of the retinoic acid receptor in mouse renal cell carcinoma.
Hara I; Taguchi I; Miyake H; Hara S; Gotoh A; Kamidono S
Int J Oncol; 2001 Nov; 19(5):959-62. PubMed ID: 11604994
[TBL] [Abstract][Full Text] [Related]
15. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
Hathorn RW; Tso CL; Kaboo R; Pang S; Figlin R; Sawyers C; deKernion JB; Belldegrun A
Cancer; 1994 Oct; 74(7):1904-11. PubMed ID: 7521786
[TBL] [Abstract][Full Text] [Related]
16. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.
Kinney P; Triozzi P; Young D; Drago J; Behrens B; Wise H; Rinehart JJ
J Clin Oncol; 1990 May; 8(5):881-5. PubMed ID: 2332772
[TBL] [Abstract][Full Text] [Related]
18. [Advanced renal cell carcinoma showing a different response to two types of interferon-alpha].
Horiguchi A; Uchida A
Nihon Hinyokika Gakkai Zasshi; 2004 Jan; 95(1):50-3. PubMed ID: 14978941
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial. The Delta-P Study Group.
Prümmer O
Cancer; 1993 Mar; 71(5):1828-34. PubMed ID: 8448744
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil number after interferon-alfa treatment is an independent predictive marker of overall survival in metastatic renal cell carcinoma.
Azuma T; Matayoshi Y; Nagase Y; Oshi M
Clin Genitourin Cancer; 2012 Sep; 10(3):180-4. PubMed ID: 22608529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
